How many insider trades does FilingIQ track for DXR?

FilingIQ tracks 101 Form 4 insider transactions for DXR (DAXOR CORP), covering filings from Jan 20, 2015 onwards. 1 of those are dated within the last 90 days.

Are DXR insiders net buyers or net sellers?

Across the full Form 4 history for DXR, 82 transactions (81%) were open-market purchases and 7 (7%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does DXR insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is DXR in?

DAXOR CORP (DXR) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $54.78M.

DXR insider trading

NasdaqCM Healthcare

DAXOR CORP: insider trade history from SEC Form 4 filings.

Total Form 4 trades

101

Last 90 days

Buys / sells

81% / 7%

Market cap

$54.78M

About DAXOR CORP

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.

Company website: www.daxor.com

DXR insider activity at a glance

FilingIQ tracks 101 insider transactions for DXR in filings since Jan 20, 2015. The most recent transaction is dated Aug 28, 2026.

Across the full history, 82 open-market purchases and 7 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on DXR insider trades is 60.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live DXR trades on FilingIQ Raw filings on SEC EDGAR

Latest DXR Form 4 filings

Jefferies John Chief Medical Officer

A Sep 1, 2026

Michel Robert J Chief Financial Officer

A Jun 25, 2026

Feldschuh Michael Richard Chief Executive Officer

A Jun 25, 2026

Feldschuh Jonathan Adam Chief Scientific Officer

Feldschuh Michael Richard Chief Executive Officer

P Apr 10, 2026

Michel Robert J Chief Financial Officer

P Mar 31, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

Frequently asked

How many insider trades does FilingIQ track for DXR?: FilingIQ tracks 101 Form 4 insider transactions for DXR (DAXOR CORP), covering filings from Jan 20, 2015 onwards. 1 of those are dated within the last 90 days.
Are DXR insiders net buyers or net sellers?: Across the full Form 4 history for DXR, 82 transactions (81%) were open-market purchases and 7 (7%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does DXR insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is DXR in?: DAXOR CORP (DXR) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $54.78M.

Methodology & sources

Every DXR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.